Formosa Laboratories offers one-stop shop service GMP manufacturing from drug substance to drug product. Our injectable facility accommodates both small molecules and biologics, from pilot scale to commercial scale, and all under general or cytotoxic control. Combining this expertise, our one-stop-shop for Antibody-Drug Conjugate manufacturing is well established. Our service scope includes antibody production (through domestic alliance), fermentation, peptide synthesis, cytotoxic/non-cytotoxic API synthesis, bio-conjugation, and fill-finish drug product manufacturing. Formosa Laboratories is fully GMP compliant and has been approved by Taiwan FDA, US FDA, BGV, EDQM, and PMDA.
more >
Year of Establishment:
1995
Total Assets(USD):
More than 99,999,999
Total Number of Staff:
500-1000
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
LINK
Business Type:
Trading Company,Service Provider,Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights:
LINK